Long established as the preeminent source in its field, the eagerly anticipated fifth edition of Dr Stahl's essential textbook of psychopharmacology is here! With its use of icons and figures that form Dr Stahl's unique 'visual language', the book is the single most readable source of information on disease and drug mechanisms for all students and mental health professionals seeking to understand and utilize current therapeutics, and to anticipate the future for novel medications. Every aspect of the book has been updated, with the clarity of explanation that only Dr Stahl can bring. The new edition includes over 500 new or refreshed figures, an intuitive color scheme, fourteen new uses for older drugs and eighteen brand new drugs, coverage of Parkinson's Disease Psychosis, behavioural symptoms of dementia, and mixed features in major depressive episodes, and expanded information on the medical uses of cannabis and hallucinogen assisted psychotherapy.

Autorentext
Stephen M. Stahl, MD, PhD is Professor of Psychiatry and Neuroscience at University of California, Riverside and at University of California, San Diego, Honorary Visiting Senior Fellow, University of Cambridge, UK, and Chairman of the Neuroscience Education Institute, Carlsbad.

Klappentext

The fully-updated fifth edition covers the essential information required to become a neurobiologically empowered psychopharmacologist.

Zusammenfassung
The fully updated fifth edition continues to present the fundamentals of psychopharmacology in a simplified and readily readable form, emphasizing current formulations of disease and drug mechanisms. The organization of information applies the principles of programmed learning, namely repetition and interaction, which enhances retention.

Inhalt

Preface to the Fifth Edition; CME Information; 1. Chemical Neurotransmission; 2. Transporters, Receptors and Enzymes as Targets of Psychopharmacological Drug Action; 3. Ion Channels as Targets of Psychopharmacological Drug Action; 4. Psychosis, Schizophrenia and the Neurotransmitter Networks Dopamine, Serotonin and Glutamate; 5. Targeting Dopamine and Serotonin Receptors for Psychosis, Mood and Beyond: So-Called 'Antipsychotics'; 6. Mood Disorders and the Neurotransmitter Networks Norepinephrine and Gamma Amino Butyric Acid (Gaba); 7. Treatments for Mood Disorders: So-Called 'Antidepressants' and 'Mood Stabilizers'; 8. Anxiety, Trauma and Treatment; 9. Chronic Pain and its Treatment; 10. Disorders of Sleep and Wakefulness and their Treatment: Neurotransmitter Networks for Histamine and Orexin; 11. Attention Deficit Hyperactivity Disorder and its Treatment; 12. Dementia: Causes, Symptomatic Treatments and the Neurotransmitter Network Acetylcholine; 13. Impulsivity, Compulsivity and Addiction; Suggested Reading and Selected References; Index.